BD and Wellstar Health System have formed a partnership to enhance the safety and efficiency of medication delivery throughout Wellstar’s hospitals and care facilities.

Medtronic has received the CE mark for its VitalFlow Transport Frame AG, which functions as an accessory to the VitalFlow ECMO system.

Olympus has signed an exclusive global agreement to distribute EndoRobotics’ robot-assisted technologies as part of its EndoTherapy portfolio.

J&J hopes Ottava will boost its standing in the growing surgical robotics market, which is currently dominated by Intuitive Surgical.

Insulet has commenced patient enrolment in its pivotal EVOLVE study, evaluating a fully closed-loop AID system for adults with T2D.

The funds will advance Axoft’s existing clinical trial programmes and progress US regulatory activities for its implantable brain-computer interface.

InspireMD has issued a voluntary recall of its CGuard Prime 135cm carotid stent delivery system in the US, following consultation with the US FDA.

According to GlobalData analyst Dr Andrew S Thompson, the deal signals Thermo Fisher’s move away from the IVD space.

TaeWoong Medical has secured the US FDA clearance to commercialise the Niti-S Spaxus Stent, expanding its range of EUS-guided therapeutic solutions.

MintNeuro has signed a partnership with Motif Neurotech to advance the development of miniature BCI therapy for mental health conditions.

VVeno Medical has received the IDE approval from the US FDA for a pivotal study involving a non-surgical replacement venous valve.

Should the transaction complete, J&J will inherit Atraverse’s radiofrequency system for simplifying access to the heart’s left atrium.